Eliglustat (Cerdelga) is a glucosylceramide synthase inhibitor. It is specifically indicated for the long-term treatment of adult patients with Type 1 Gaucher disease who have been confirmed as CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) through FDA-recognized testing.

How to Purchase Eliglustat (Cerdelga)

Overseas Purchase

Patients may choose to consult and purchase the medication at hospital pharmacies or licensed drugstores in countries or regions where eliglustat has been approved for marketing.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase through Medical Service Institutions

Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and can offer professional consultation and guidance.

Precautions Before Purchasing Eliglustat (Cerdelga)

Mandatory Medical Evaluation

A comprehensive medical evaluation must be completed before purchasing eliglustat.

Physicians need to assess factors such as the patient’s cardiac function, liver status, and infection risk. These evaluation results directly affect the formulation of the treatment plan.

Key Points for Dosage Confirmation

For extensive metabolizers (EMs) and intermediate metabolizers (IMs): 84 mg taken orally twice daily.

For poor metabolizers (PMs): 84 mg taken orally once daily.

Drug Interactions

Concomitant use with strong CYP3A inhibitors should be avoided.

Concomitant use with strong or moderate CYP3A inducers should be avoided.

Concomitant use with certain antiarrhythmic drugs (e.g., Class IA and Class III) should be avoided.

How to Distinguish Genuine from Counterfeit Eliglustat (Cerdelga)

Identification of Packaging Features

Genuine eliglustat is manufactured by Genzyme Corporation, and the packaging should have clear brand logos.

Each box contains either 4 blister packs (total 56 capsules) or 1 blister pack (total 14 capsules), packaged in blister packs and cardboard wallets.

Verification of Physical Characteristics

Authentic capsules have specific appearance features: a pearlescent blue-green opaque cap and a pearlescent white opaque body, with "GZ02" printed in black on the capsule.

Verification of Production Information

Medications purchased through formal channels will provide complete traceability information, including the approval number, production batch number, and expiration date.